SEQUANA MEDICAL
Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body. This system is designed to move excess fluid to the bladder, where it is passed naturally from the body through normal urination. Sequana Medical’s first product, the Alfapump System, is an innovative solution for the management of ascites. Ascites is a fluid that collects in the abdominal cavity in people with advanced liver disease, certain cancers, or congestive heart failure. Alfapump System was the first and only system for the automatic and continual removal of ascites. Sequana Medical was founded in 2006 and is based in Zurich, Switzerland.
SEQUANA MEDICAL
Industry:
Biotechnology Health Care Manufacturing Medical Device
Founded:
2006-01-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.sequanamedical.com
Total Employee:
11+
Status:
Active
Contact:
+41 44 403 55 00
Email Addresses:
[email protected]
Total Funding:
101.83 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome Apache
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Kreos Capital
Kreos Capital investment in Post-IPO Debt - Sequana Medical
PMV
PMV investment in Series D - Sequana Medical
Neomed Management
Neomed Management investment in Series D - Sequana Medical
Newton Biocapital
Newton Biocapital investment in Series D - Sequana Medical
SFPI-FPIM
SFPI-FPIM investment in Series D - Sequana Medical
Entrepreneurs Fund
Entrepreneurs Fund investment in Series C - Sequana Medical
Quest for Growth
Quest for Growth investment in Series C - Sequana Medical
Neomed Management
Neomed Management investment in Series C - Sequana Medical
VI Partners
VI Partners investment in Series C - Sequana Medical
Life Sciences Partners
Life Sciences Partners investment in Series C - Sequana Medical
Official Site Inspections
http://www.sequanamedical.com Semrush global rank: 2 M Semrush visits lastest month: 10.6 K
- Host name: 212.78.11.32
- IP address: 212.78.11.32
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
More informations about "Sequana Medical"
About us - Sequana Medical
[email protected]. Sequana Medical NV Kortrijksesteenweg 1112 9051 Sint-Denijs Westrem Belgium . × Source GlobalData NASH Epidemiology Forecast to 2026. ... World Health Organization International Agency for …See details»
Executive team - Sequana Medical
[email protected]. Sequana Medical NV Kortrijksesteenweg 1112 9051 Sint-Denijs Westrem Belgium . × Source GlobalData NASH Epidemiology Forecast to 2026. ... World …See details»
Sequana Medical - Crunchbase Company Profile & Funding
Organization. Sequana Medical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»
Sequana Medical NV | LinkedIn
Sequana Medical NV is a pioneer in treating drug-resistant fluid overload, a serious and frequent clinical complication in patients with liver disease, heart failure and cancer. Fluid overload is ...See details»
Sequana Medical - Overview, News & Similar companies - ZoomInfo
Apr 22, 2024 Sequana Medical contact info: Phone number: +32 92982828 Website: www.sequanamedical.com What does Sequana Medical do? Sequana Medical is a medical …See details»
Sequana Medical - PitchBook
Sequana Medical General Information Description. Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, …See details»
Company Sequana Medical N.V. - MarketScreener.com
Dec 31, 2015 Sequana Medical N.V. is a commercial stage medical device company utilizing its proprietary alfapump® and DSR® (Direct Sodium Removal) technologies to develop …See details»
Sequana Medical
The alfapump® system is currently not approved in the United States or Canada.In the United States and Canada, the alfapump® system is currently under clinical investigation …See details»
Sequana Medical - Craft
Oct 29, 2024 Sequana Medical has 5 employees across 3 locations and €712 k in annual revenue in FY 2023. See insights on Sequana Medical including office locations, competitors, …See details»
Alexandra Clyde appointed to Sequana Medical Board of Directors
Aug 25, 2022 [email protected]. Sequana Medical NV Kortrijksesteenweg 1112 9051 Sint-Denijs Westrem Belgium . × Source GlobalData NASH Epidemiology Forecast to 2026. ...See details»
Sequana Medical Announces the Appointments of Industry …
GHENT, Belgium – November 8, 2018 – Sequana Medical NV (“Sequana Medical” or “the Company”), a commercial stage medical device company focused on the development of …See details»
Sequana Medical announces 2022 Full Year Results and 2023
Feb 9, 2023 E: [email protected] T: +32 (0)498 05 35 79. Optimum Strategic Communications Nick Bastin, Jonathan Edwards, Vici Rabbetts E: …See details»
Investors - Sequana Medical
Sep 19, 2024 [email protected]. Sequana Medical NV Kortrijksesteenweg 1112 9051 Sint-Denijs Westrem Belgium . × Source GlobalData NASH Epidemiology Forecast to 2026. ...See details»
Contact us - Sequana Medical
[email protected]. Sequana Medical NV Kortrijksesteenweg 1112 9051 Sint-Denijs Westrem Belgium . × Source GlobalData NASH Epidemiology Forecast to 2026. ... World …See details»
SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 28.4 MILLION IN …
Mar 8, 2022 Email: [email protected]. LifeSci Advisors Guillaume van Renterghem Tel: +41 76 735 01 31 Email: [email protected]. About Sequana MedicalSee details»
Sequana Medical Notice of 2022 Full Year Results and Business …
PRESS RELEASE Ghent, Belgium – 2 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of fluid overload in …See details»
Sequana Medical announces 2021 Full Year Results and 2022 …
Apr 12, 2022 For further information, please visit www.sequanamedical.com. ... World Health Organization International Agency for Research on Cancer 2018 (estimated number of new …See details»
Sequana Medical Notice of 2022 Half Year Results and Business …
Ghent, Belgium – 1 September 2022 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of drug-resistant fluid overload in …See details»
Sequana Medical announces H1 2021 results and provides …
Sep 2, 2021 PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 2 September 2021, 07:00 CET alfapump® – Positive results from second interim analysis of …See details»